May 10 (Reuters) - Voyager Therapeutics Inc:
* VOYAGER THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS
* Q1 EARNINGS PER SHARE VIEW $-0.11 -- THOMSON REUTERS I/B/E/S
* CASH, CASH EQUIVALENTS, AND MARKETABLE DEBT SECURITIES AS OF MARCH 31, 2018 WERE $218.2 MILLION
* VOYAGER THERAPEUTICS - CONTINUES TO EXPECT TO END 2018 WITH TOTAL CASH, CASH EQUIVALENTS, MARKETABLE DEBT SECURITIES OF ABOUT $125 MILLION TO $135 MILLION
* VOYAGER THERAPEUTICS - PROJECTS TO CURRENTLY BE ABLE TO FUND OPERATING EXPENSES, CAPEX REQUIREMENTS INTO EARLY 2020 Source text for Eikon: Further company coverage:
